Assay Detail
Binding
CHEMBL5730868
Review assay metadata, readout intent, target linkage, and publication context from the same page.
mmTV-luciferase reporter assay: An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antagonists) on this process is measured by quantifying the amount of luciferase activity after 24 hours in the presence of varying concentrations of antiandrogens. From these values, an IC50 for each antagonist is calculated. Experimentally, HeLa cells were maintained in Dulbecco's modified Eagle's medium H-21 4.5 g/L glucose, containing 10% steroid depleted fetal bovine serum, 50 units/mL penicillin. For transfection, (1×105) cells per well were plated and incubated overnight. A mixture of typically 200 ng of mmTV responsive luciferase reporter plasmid, 10 ng of β-actin-β-galactosidase internal control, 10 ng of AR full length CMV expression vector or empty vector control, and 10-100 ng of β-catenin or empty vector control were mixed with 0.5 μL of transfection reagent from BioRad and incubated for 20 min and then plated in 24 well plate triplicates. Cells were induced with 1 nM DHT and 0.1 nM-30 uM compounds after 3 hrs and then incubated overnight. Cells were collected, and pellets were lysed in 100 μL of 100 mM Tris-HCl (pH 7.5) containing 0.1% Triton X-100. Luciferase and β-galactosidase activities were measured using the Luciferase Assay System (Promega) and Galacto-Light Plus-galactosidase reporter gene assay system (Applied Biosystems), according to the manufacturer's instructions.
24
Total Activities
7
Compounds Tested
3
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Androgen receptor antagonists
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 8 | 5.31 | 6.72 |
| kon | 8 | - | - |
| k_off | 8 | - | - |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5893645 | — | — | 6 | 6.72 |
| CHEMBL5740755 | — | — | 3 | 5.89 |
| CHEMBL1082407 | ENZALUTAMIDE | 4.0 | 3 | 5.07 |
| CHEMBL5744517 | — | — | 3 | 5.06 |
| CHEMBL5955311 | — | — | 3 | 4.91 |
| CHEMBL3183409 | APALUTAMIDE | 4.0 | 3 | 4.71 |
| CHEMBL5887736 | — | — | 3 | 4.14 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5893645 | — | IC50 | = | 190.0 | nM | 6.72 |
| CHEMBL5893645 | — | IC50 | = | 1000.0 | nM | 6.00 |
| CHEMBL5740755 | — | IC50 | = | 1290.0 | nM | 5.89 |
| CHEMBL1082407 | ENZALUTAMIDE | IC50 | = | 8610.0 | nM | 5.07 |
| CHEMBL5744517 | — | IC50 | = | 8740.0 | nM | 5.06 |
| CHEMBL5955311 | — | IC50 | = | 12400.0 | nM | 4.91 |
| CHEMBL3183409 | APALUTAMIDE | IC50 | = | 19500.0 | nM | 4.71 |
| CHEMBL5887736 | — | IC50 | = | 71700.0 | nM | 4.14 |
| CHEMBL5893645 | — | kon | = | - | — | - |
| CHEMBL5893645 | — | k_off | = | - | s-1 | - |
| CHEMBL5893645 | — | kon | = | - | — | - |
| CHEMBL5893645 | — | k_off | = | - | s-1 | - |
| CHEMBL5887736 | — | kon | = | - | — | - |
| CHEMBL5887736 | — | k_off | = | - | s-1 | - |
| CHEMBL5955311 | — | kon | = | - | — | - |
| CHEMBL5955311 | — | k_off | = | - | s-1 | - |
| CHEMBL5744517 | — | kon | = | - | — | - |
| CHEMBL5744517 | — | k_off | = | - | s-1 | - |
| CHEMBL1082407 | ENZALUTAMIDE | kon | = | - | — | - |
| CHEMBL1082407 | ENZALUTAMIDE | k_off | = | - | s-1 | - |
| CHEMBL3183409 | APALUTAMIDE | kon | = | - | — | - |
| CHEMBL3183409 | APALUTAMIDE | k_off | = | - | s-1 | - |
| CHEMBL5740755 | — | kon | = | - | — | - |
| CHEMBL5740755 | — | k_off | = | - | s-1 | - |